With this in mind, Coulouarnet al. used transcriptome analysis to identify early and late TGFβ signatures in HCC and showed that the late TGFβ signature was associated with shortened survival time compared with patients with the early TGFβ signature. Here, TGFB1 is linked to hepatocellular carcinoma.